Merck & Co Inc
NYSE: MRK
$98.50
-$0.08 (-0.1%)
Closing Price on November 13, 2024
MRK Articles
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Published:
Fourth-quarter earnings kick off in a big way in 7 to 10 days, and earnings at some of the biggest and best U.S. companies are likely expected to decline for the third quarter running. Many top...
Published:
While many investment professionals suggest short Treasury paper and money markets, healthcare is the place in 2024 for long-term investors looking for growth and income. Demand is growing as the...
Published:
This year’s Artificial Intelligence rally led by the so-called “Magnificent 7” has been fantastic if you owned those stocks. The reality is the great bulk of the S&P 500 is treading water...
Published:
If any investor has stood the test of time, it’s Warren Buffett, and with good reason. For years, the “Oracle of Omaha” has had a rock star-like presence in the investing world, and his annual...
Published:
2023 has been a much better year than 2022, as all major indices are higher. The tech-heavy Nasdaq is up a whopping 32.5%, while the venerable S&P 500 is up 15.36% and the Dow Jones Industrial...
Published:
While many Wall Street firms are suggesting short Treasury paper and money markets now, for long-term investors looking for growth and income, healthcare is the place to be for the rest of 2023 and...
Published:
Before U.S. markets open on Thursday, Comcast, Merck and two others will report quarterly results. Our earnings previews let you know what analysts expect to hear.
Published:
Here are six top dividend-paying blue chip stock picks from the Goldman Sachs Conviction List that are ideal for worried investors. They should be able to hold their own if there is a sizable market...
Published:
These seven companies typically do not feel as much pressure from rising input costs and so likely still will be standing years from now. Thus, these outstanding inflation-fighting stocks make good...
Published:
Two pharmaceutical giants, one a Dow component, report quarterly results before markets open on Thursday. A major airline and a tobacco company are also on the schedule.
Published:
Friday's top analyst upgrades and downgrades included American Airlines, Broadcom, Chevron, DraftKings, Enphase Energy, EOG Resources, Exxon Mobil, First Solar, Hertz Global, LyondellBasell...
Published:
With a recession likely on the way, health care is the place to be in 2023 for long-term investors looking for growth and income. These seven industry leaders offer solid total return potential in a...
Published:
With the second quarter now underway, these seven top dividend-paying Goldman Sachs stock picks make sense for growth and income investors who are looking for stocks that are still offering...
Published:
Tuesday's top analyst upgrades and downgrades included Ally Financial, Amgen, Baidu, Bilibili, Bill.com, Coinbase Global, Eli Lilly, GE Healthcare Technologies, JPMorgan Chase, Merck, Moderna,...
Published: